Immunological and anticoagulant properties of anti-prothrombin (LA) antibodies

被引：0
|
作者：
Galli, M
Ruggeri, L
Daldossi, M
Beretta, G
Bevers, EM
Barbui, T
机构：
[1] OSPED RIUNITI BERGAMO, DIV EMATOL, I-24100 BERGAMO, ITALY
[2] INST CARDIOVASC RES, DEPT BIOCHEM, MAASTRICHT, NETHERLANDS
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：OC685 / OC685
页数：1
相关论文
共 50 条
  • [31] Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?
    Galli, M
    JOURNAL OF AUTOIMMUNITY, 2000, 15 (02) : 101 - 105
  • [32] Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism
    Zanon, E
    Saggiorato, G
    Ramon, R
    Girolami, A
    Pagnan, A
    Prandoni, P
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) : 255 - 258
  • [33] Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome
    Sciascia, Savino
    Sanna, Giovanni
    Murru, Veronica
    Roccatello, Dario
    Khamashta, Munther A.
    Bertolaccini, Maria Laura
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (02) : 354 - 364
  • [34] Anti-prothrombin but not "pure" anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibodies are associated
    Sorice, H
    Pittoni, V
    Circella, A
    Misasi, R
    Conti, F
    Longo, A
    Pontieri, GM
    Valesini, G
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (04) : 713 - 715
  • [35] Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity
    Yang, Yao-Hsu
    Chang, Chun-Jung
    Chuang, Ya-Hui
    Hsu, Hui-Yao
    Chen, Pojen P.
    Chiang, Bor-Luen
    RHEUMATOLOGY, 2010, 49 (01) : 34 - 42
  • [36] Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome
    Donohoe, S
    Mackie, IJ
    Isenberg, D
    Machin, SJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 544 - 549
  • [37] Anti-beta(2)-glycoprotein I and anti-prothrombin antibodies in haemodialysis patients
    Ducloux, D
    Florea, A
    Rebibou, JM
    Jamali, M
    Chalopin, JM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (11) : 2466 - 2467
  • [38] Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus
    Nojima, J
    Kuratsune, H
    Suehisa, E
    Futsukaichi, Y
    Yamanishi, H
    Machii, T
    Kitani, T
    Iwatani, Y
    Kanakura, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) : 647 - 654
  • [39] Experimental Hypoprothrombinemia with anti-prothrombin serum
    Tocantins, LM
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1940, 43 (04): : 729 - 731
  • [40] Effect of anti-β2-glycoprotein I and anti-prothrombin antibodies on platelet activation
    Ruggeri, L
    Galli, M
    Barbui, T
    THROMBOSIS AND HAEMOSTASIS, 1999, : 101 - 102
12345